Literature DB >> 27430663

Epstein-Barr virus strains and variations: Geographic or disease-specific variants?

Marco Neves1,2, Joana Marinho-Dias1,3,4, Joana Ribeiro1,2,3, Hugo Sousa1,3.   

Abstract

The Epstein-Barr Virus (EBV) is associated with the development of several diseases, including infectious mononucleosis (IM), Burkitt's Lymphoma (BL), Nasopharyngeal Carcinoma, and other neoplasias. The publication of EBV genome 1984 led to several studies regarding the identification of different viral strains. Currently, EBV is divided into EBV type 1 (B95-8 strain) and EBV type 2 (AG876 strain), also known as type A and type B, which have been distinguished based upon genetic differences in the Epstein-Barr nuclear antigens (EBNAs) sequence. Several other EBV strains have been described in the past 10 years considering variations on EBV genome, and many have attempted to clarify if these variations are ethnic or geographically correlated, or if they are disease related. Indeed, there is an increasing interest to describe possible specific disease associations, with emphasis on different malignancies. These studies aim to clarify if these variations are ethnic or geographically correlated, or if they are disease related, thus being important to characterize the epidemiologic genetic distribution of EBV strains on our population. Here, we review the current knowledge on the different EBV strains and variants and its association with different diseases. J. Med. Virol. 89:373-387, 2017.
© 2016 Wiley Periodicals, Inc. © 2016 Wiley Periodicals, Inc.

Entities:  

Keywords:  Epstein-Barr virus; genetic variation; oncogenesis; pathology; virus classification

Mesh:

Year:  2016        PMID: 27430663     DOI: 10.1002/jmv.24633

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  22 in total

Review 1.  Phylogenetic comparison of Epstein-Barr virus genomes.

Authors:  Su Jin Choi; Seok Won Jung; Sora Huh; Hyosun Cho; Hyojeung Kang
Journal:  J Microbiol       Date:  2018-06-14       Impact factor: 3.422

2.  Early Epstein-Barr Virus Genomic Diversity and Convergence toward the B95.8 Genome in Primary Infection.

Authors:  Eric R Weiss; Susanna L Lamers; Jennifer L Henderson; Alexandre Melnikov; Mohan Somasundaran; Manuel Garber; Liisa Selin; Chad Nusbaum; Katherine Luzuriaga
Journal:  J Virol       Date:  2018-01-02       Impact factor: 5.103

3.  HER-2/Epstein-Barr virus crosstalk in human gastric carcinogenesis: A novel concept of oncogene/oncovirus interaction.

Authors:  Farhan S Cyprian; Noor Al-Antary; Ala-Eddin Al Moustafa
Journal:  Cell Adh Migr       Date:  2017-06-29       Impact factor: 3.405

4.  Association between Epstein-Barr Virus Gene Polymorphism and Breast Cancer Risk among Egyptian Females.

Authors:  Meravt Mashaly; Doaa Ghorab; Mohamed Hegazy; Mohamed Abdelkhalek; Khaled Gaballah; Rasha Elzehery
Journal:  Asian Pac J Cancer Prev       Date:  2022-02-01

5.  Carcinoma-risk variant of EBNA1 deregulates Epstein-Barr Virus episomal latency.

Authors:  Jayaraju Dheekollu; Kimberly Malecka; Andreas Wiedmer; Henri-Jacques Delecluse; Alan K S Chiang; Dario C Altieri; Troy E Messick; Paul M Lieberman
Journal:  Oncotarget       Date:  2017-01-31

6.  A novel recombinant variant of latent membrane protein 1 from Epstein Barr virus in Argentina denotes phylogeographical association.

Authors:  Magdalena Gantuz; Mario Alejandro Lorenzetti; Paola Andrea Chabay; María Victoria Preciado
Journal:  PLoS One       Date:  2017-03-22       Impact factor: 3.240

7.  Comprehensive Evolutionary Analysis of Complete Epstein-Barr Virus Genomes from Argentina and Other Geographies.

Authors:  Ana Catalina Blazquez; Ariel José Berenstein; Carolina Torres; Agustín Izquierdo; Carol Lezama; Guillermo Moscatelli; Elena Noemí De Matteo; Mario Alejandro Lorenzetti; María Victoria Preciado
Journal:  Viruses       Date:  2021-06-18       Impact factor: 5.048

8.  Investigation of Long COVID Prevalence and Its Relationship to Epstein-Barr Virus Reactivation.

Authors:  Jeffrey E Gold; Ramazan A Okyay; Warren E Licht; David J Hurley
Journal:  Pathogens       Date:  2021-06-17

9.  Computer-Aided Design of an Epitope-Based Vaccine against Epstein-Barr Virus.

Authors:  Julio Alonso-Padilla; Esther M Lafuente; Pedro A Reche
Journal:  J Immunol Res       Date:  2017-09-28       Impact factor: 4.818

10.  Antibodies to a strain-specific citrullinated Epstein-Barr virus peptide diagnoses rheumatoid arthritis.

Authors:  Nicole Hartwig Trier; Bettina Eide Holm; Julie Heiden; Ole Slot; Henning Locht; Hanne Lindegaard; Anders Svendsen; Christoffer Tandrup Nielsen; Søren Jacobsen; Elke Theander; Gunnar Houen
Journal:  Sci Rep       Date:  2018-02-27       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.